Andrzej Szuba

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction

Rainer H. Böger, Stefanie M. Bode‐Böger, Andrzej Szuba et al. · Circulation · 1998 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacology +12

Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

Mahshid Dehghan, Andrew Mente, Xiaohe Zhang et al. · The Lancet · 2017 · 1.1K citations

Public Health, Nutrition, Nutritional Sciences +14

Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

Salim Yusuf, Sumathy Rangarajan, Koon Teo et al. · New England Journal of Medicine · 2014 · 995 citations · Full text

Medicine, Cardiology, Epidemiology +14

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13